lobbying_activities: 2461072

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2461072	243a51c0-4899-4cdd-a929-ff67b6b11f6f	Q2	EAST END GROUP, LLC	400646949	BAYER CORPORATION	2020	second_quarter	HCR	General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2020-07-03T12:01:33.143000-04:00